15^th World Congress on Blood Cancer October 23-24, 2019 Prague, Czech Republic

PANAROMA HOTEL PRAGUE - Milevská 7, 140 63 Praha 4-Nusle, Czechia

Individuals from around the world concentrated on research about blood cancer; this is one of most obvious opportunity to achieve the greatest array of members from the Cancer community. Top introductions, appropriate data, meet with ebb and flow and potential researchers, make a sprinkle with new advancements and inquire about, and get name acknowledgment at this 2-day occasion. Cancer analysts from around the world, the latest procedures, developments, and the most current updates in Leukemia determination, treatment and medical procedure included are signs of this gathering.

This is one of the Exclusive Chance for Advertisers and Sponsors at this worldwide event

Target Audience:

• Blood cancer researchers
• Hematologists
• Cancer Specialists
• Oncologists
• Medical Oncologists
• Immunologists
• Pathologists
• Research Scholars
• Industrial professionals
• Medical Students
• Nurse Practitioners
• Principle Investigators & Directors
• Laboratory Researchers
• Group Leaders
• Cancer Diagnostic Professionals
• Cancer & Oncology Societies Professionals
• Bio-Medical Company professionals
• Healthcare Industries
• Directors of Association and Societies
• Researchers, Training Institutes

Track-1

Various Blood Cancers & their Management

There are mainly three types of blood cancers. Leukemia is one type of cancer it is found in bone marrow and blood. It is affected by the quick production of abnormal white blood cells. These abnormal white blood cells are not able to fight infection and damage the capability of the bone marrow to produce red blood cells and platelets. Leukemia is also acute or chronic. Acute leukemia grows faster than chronic leukemia, which needs instant treatment. This leukemia is categorized as myelogenous or lymphocytic.

Lymphoma will be directly attack the immune system, these are called lymphocytes. These cells are in the lymph nodes, spleen, thymus, bone marrow, and other parts of the body. When you have lymphoma, lymphocytes variation and produce out of control.

Myeloma is malignancy of the plasma cells. Plasma cells are white platelets that deliver sickness and disease battling antibodies in your body. Myeloma cells have the usual generation of antibodies, leaving your body's safe framework debilitated and defenseless to disease. The augmentation of myeloma cells additionally meddles with the ordinary generation and capacity of red and white platelets. Multiple myeloma, well-known as plasma cell myeloma, is a cancer of plasma cells, a type of white blood cell generally responsible for producing antibodies. Regularly, no side effects are seen at first. Whenever propelled, bone pain, Bleeding, frequent infections, and anemia may occur.

Leukemia

• Acute lymphocytic leukemia (ALL)
• Acute myelogenous leukemia (AML)
• Chronic lymphocytic leukemia (CLL)
• Chronic myelogenous leukemia (CML)
• Leukemia occurs in both adults and children.

Lymphoma

• Hodgkin lymphoma
• Non-Hodgkin lymphoma

Myeloma

• Multiple myeloma

Hematology Societies in Europe

Association of European Cancer Leagues, Europe; British Society for Haematology, Europe; Egyptian Society of Hematology and Research;  ESMO: European Society for Medical Oncology, Europe; European Academy of Cancer Sciences, Europe; European Association for Cancer Research, Europe; European Cancer Organization: ECCO, Europe; European Organization for Research and Treatment of Cancer, Europe;  European Prostate Cancer Coalition, Europe; European School of Oncology, Europe; European Society for Pediatric Oncology – SIOPE, Europe; European Society of Skin Cancer Prevention, Europe: European Society of Surgical Oncology, Europe;  Federation of European Cancer Societies, Europe; International Society of Pediatric Oncology, Europe;  Organization of European Cancer Institute, Europ

Track-2

Diagnosis & Screening of Blood Cancer

Types of blood cancers are diagnosed with blood tests and biopsies, but people may also need scans to monitor the symptoms or see how the treatment is working. The tests will be depends on the symptoms and what type of blood cancer having in blood sample.

The detailed information on different types of blood cancer is diagnosed so if people are worried about they have been diagnosed with a certain type of blood cancer. If people have the symptom of screening test result suggests cancer, and also it find out due to cancer or some other cause. Some flow cytometry and cytogenetic testing can also be done using a sample from a blood test.

Screening & Diagnosis tests of blood cancer:

• Complete blood count (CBC)
• Lab Tests
• Imaging Procedures   
• Nuclear scan
• Full blood count (FBC)
• Infection screening / virology testing
• Liver function tests
• Peripheral blood film
• Urea and electrolytes
• Other tests

Hematology Societies in Asia-Pacific

Asia Pacific Hematology Consortium, Asia-Pacific; Asian and Pacific Federation of Organizations for Cancer Research and Control, Asia-Pacific; Asian Cancer Foundation, Asia-Pacific; Asian Clinical Oncology Society: ACOS, Asia-Pacific; Asian Fund for Cancer Research, Asia-Pacific; Asian Hematology Association, Asia-Pacific; Asian Society of Gynecologic Oncology, Asia-Pacific; Australasian Lung Cancer Trials Group, Asia-Pacific ; Black Sea Countries Coalition on Breast and Cervical Cancer Prevention, Asia-Pacific ; Cancer Therapeutics Research Group, Asia-Pacific; Japanese Society of Hematology, Asia-Pacific ; Pan Arab Hematology Association, Asia-Pacific; The Thai Society of Hematology, Asia-Pacific

Track-3

Treatment of Blood Cancer

There are so many different types of cancer treatments are there with different possible benefits, risks and side effects. Slow-growing blood cancers can be survived by taking daily medication, whereas people with faster-growing acute blood cancers may need stronger (intensive) treatments. A stem cell transplant infuses healthy blood-forming stem cells into the body.

Chemotherapy is also one of the anticancer drugs designed to interfere with and halt the growth of cancer cells in the body. Cancer cells are destroyed and relieve pain or discomfort by Radiation therapy. It may also be given before a stem cell transplant.

Types of treatments:

• Intensive treatment / high-intensity treatment
• Chemotherapy
• Stem cell transplantation
• Radiation therapy
• Non-intensive / low-intensity treatment
• Low-dose chemotherapy
• Curative treatment
• Non-curative treatments

Hematology Societies in USA

American Brain Tumor Association, USA; American Cancer Society, USA; American Childhood Cancer Organization, USA; American Head and Neck Society, USA; American Society for Radiation Oncology, USA; American Society of Clinical Oncology, USA; Association of Community Cancer Centers, USA; Canadian Hematology Society, USA; Childhood Brain Tumor Foundation, USA; Children's Tumor Foundation, USA; Colon Cancer Alliance, USA; Foundation for Women's Cancer, USA; International Society for Laboratory Hematology, USA; International Society of Hematology, USA; International Society on Thrombosis and Haemostasis, Inc, USA; Lung Cancer Foundation of America, USA; Lymphoma Research Foundation, USA; Mexican Society of Hematology, USA; Michigan Society of Hematology and Oncology, USA

Track-4

Clinical Trials of Blood Cancer

Clinical trials are nothing but the research studies designed to evaluate devices, new drugs and treatment strategies. With this any of treatment, there are benefits and risks, but joining in a clinical trial can allow us to play a more active role in our own healthcare. Earlier they are widely available to gain new research treatments, and help others by contributing to the body of medical research.

Leukemia clinical trials:

• Acute myeloid leukaemia (AML)
• Childhood acute lymphoblastic leukaemia (Ch-ALL)
• Chronic lymphocytic leukaemia (CLL)
• Chronic myeloid leukaemia (CML)
• Chronic myelomonocytic leukaemia (CMML)

Lymphoma clinical trials

• Burkitt lymphoma
• Childhood Hodgkin lymphoma (Ch-HL)
• DLBCL
• Hodgkin lymphoma
• Peripheral T-cell lymphoma (PTCL)
• Post-transplant lymphoproliferative disorder (PTLD)
• PCNSL

Myeloma clinical trials

• Myeloma

• Mini transplants
• Preventing relapse post stem cell transplant

Hematology Societies in South Africa

Africa Cancer Foundation, Africa; African Cancer Registry Network, Africa; African Journal of Cancer | Mediterranean Oncology Society, Africa; African Organization for Research and Training in Cancer, Africa; African Women’s Cancer Awareness Association, Africa; Afrox - Improving Cancer Care in Africa; CHOC Childhood Cancer Foundation South Africa; Haematology and Oncology Society of Africa; Morocco - World Health Organization Africa; Oncology for Africa ONLUS – Afron, Africa;  South African Clinical Haematology Society, Africa; South African Society of Haematology, Africa; World Health Organisation- Africa Region

Track-5

Advanced Therapies in Blood Cancer

The most important cancer cure technologies are combined with natural therapies to help patent fight the disease and maintain patent quality of life. Cancer also tested by chemotherapy, radiation therapy, surgery, hormonal therapy, immunotherapy and synthetic lethality. This therapy is depends upon the grade and place of the tumor and also, the stage of the disease, as well as the general state of the patient. The removal of cancer without damage to the rest of body is the ideal goal of treatment and is often the goal in practice.

Types of therapies:

• Radiofrequency Ablation
• Cryosurgical Ablation (CSA)
• Cancer Microvascular Intervention (CMI)
• NanoKnife Therapy
• Photodynamic Therapy
• Immunotherapy
• Hyperthermia
• Traditional Chinese Medicine

Hematology Societies in Europe

Association of European Cancer Leagues, Europe; British Society for Haematology, Europe; Egyptian Society of Hematology and Research;  ESMO: European Society for Medical Oncology, Europe; European Academy of Cancer Sciences, Europe; European Association for Cancer Research, Europe; European Cancer Organization: ECCO, Europe; European Organization for Research and Treatment of Cancer, Europe;  European Prostate Cancer Coalition, Europe; European School of Oncology, Europe; European Society for Pediatric Oncology – SIOPE, Europe; European Society of Skin Cancer Prevention, Europe: European Society of Surgical Oncology, Europe;  Federation of European Cancer Societies, Europe; International Society of Pediatric Oncology, Europe;  Organization of European Cancer Institute, Europe

Track-6

Epidemiology  of Blood Cancer

The study of factors effecting blood cancer is called as epidemiology, as a way to infer probable trends and causes. Principle period predisposition is the idea that early determination may misleadingly blow up the survival insights of a malignancy, without extremely enhancing the common history of the infection.

The investigation of malignancy the study of epidemiology transmission utilizes epidemiological techniques to discover the reason for tumor and to recognize and create enhanced medications enhancing the regular history of the malady. Length predisposition is the idea that slower developing, more slothful tumors will probably be analyzed by screening tests, however upgrades in diagnosing more instances of sluggish disease may not convert into better patient results after the execution of screening programs. A related concern is over analysis, the inclination of screening tests to analyze illnesses that may not really affect the patient's life span. This issue particularly applies to prostate malignancy and PSA screening.

Hematology Societies in Asia-Pacific

Asia Pacific Hematology Consortium, Asia-Pacific; Asian and Pacific Federation of Organizations for Cancer Research and Control, Asia-Pacific; Asian Cancer Foundation, Asia-Pacific; Asian Clinical Oncology Society: ACOS, Asia-Pacific; Asian Fund for Cancer Research, Asia-Pacific; Asian Hematology Association, Asia-Pacific; Asian Society of Gynecologic Oncology, Asia-Pacific; Australasian Lung Cancer Trials Group, Asia-Pacific ; Black Sea Countries Coalition on Breast and Cervical Cancer Prevention, Asia-Pacific ; Cancer Therapeutics Research Group, Asia-Pacific; Japanese Society of Hematology, Asia-Pacific ; Pan Arab Hematology Association, Asia-Pacific; The Thai Society of Hematology, Asia-Pacific

Track-7

Blood Cancer Palliative Care & Survivors

Palliative care means care or treatment that will help you to cure these cancer symptoms. The aim of the palliative care is to give us a good quality of life and look after the emotional and physical well-being. While tacking other kind of treatments for cancer we can still use the palliative care.

The blood cancer survivor is the person who is suffering with blood cancer and still living.

The person becomes a survivor at the time of treatment or after completing diagnosis and actively dying are considered survivors, and whether family members and healthy friends of the cancer patient are considered survivors, varies from group to group. People diagnosed with cancer reject disagree or term survivor with some definitions of it.

This definition is used for the calculation it depends up on how many people are cancer survivors. At present almost 65% of adults diagnosed with cancer in the developed world are expected to live at least five years after the cancer is discovered. For example in USA 11 million american’s are today-one in 30 people are currently undergoing for the treatment of cancer or have done in the past.

Many cancer survivors describe the process of living with and beating cancer as a life-changing experience. It isn't extraordinary for survivors to utilize the experience as open doors for innovative self-change into a "superior individual" or as inspiration to meet objectives of awesome individual significance, for example, climbing a mountain or accommodating with an antagonized relative. This procedure of posttraumatic development is called advantage finding.

Hematology Societies in USA

American Brain Tumor Association, USA; American Cancer Society, USA; American Childhood Cancer Organization, USA; American Head and Neck Society, USA; American Society for Radiation Oncology, USA; American Society of Clinical Oncology, USA; Association of Community Cancer Centers, USA; Canadian Hematology Society, USA; Childhood Brain Tumor Foundation, USA; Children's Tumor Foundation, USA; Colon Cancer Alliance, USA; Foundation for Women's Cancer, USA; International Society for Laboratory Hematology, USA; International Society of Hematology, USA; International Society on Thrombosis and Haemostasis, Inc, USA; Lung Cancer Foundation of America, USA; Lymphoma Research Foundation, USA; Mexican Society of Hematology, USA; Michigan Society of Hematology and Oncology, USA

Track-8

Blood Cancer Case Reports

Blood cancer and oncology case reports allude to the investigation of the science of growth and tumors at the atomic scale. Oncology relies upon indicative apparatuses like biopsy or expulsion of bits of the tumor tissue and endoscopy for the gastrointestinal tract, imaging ponders like X-beams, CT checking, MRI filtering, ultrasound and other radiological systems, Scintigraphy. In Medication, a case report is a point by point report of the side effects, signs, analysis, treatment, and follow-up of an individual patient.

Case reports may contain a statistic profile of the patient, however generally depict an unordinary or novel event. Some case reports likewise contain a writing survey of other revealed cases. Generally a case report is considered as a type of anecdotal evidence. Given their characteristic methodological constraints, including absence of measurable testing, case reports are put at the foot of the progression of clinical proof, together with case arrangement.

Hematology Societies in South Africa

Africa Cancer Foundation, Africa; African Cancer Registry Network, Africa; African Journal of Cancer | Mediterranean Oncology Society, Africa; African Organization for Research and Training in Cancer, Africa; African Women’s Cancer Awareness Association, Africa; Afrox - Improving Cancer Care in Africa; CHOC Childhood Cancer Foundation South Africa; Haematology and Oncology Society of Africa; Morocco - World Health Organization Africa; Oncology for Africa ONLUS – Afron, Africa;  South African Clinical Haematology Society, Africa; South African Society of Haematology, Africa; World Health Organisation- Africa Region

Track-9

Biomarkers in Blood Cancer

A biomarker might be an atom discharged by a tumor or a particular reaction of the body to the nearness of blood cancer. Hereditary, epigenetic, proteomic, glycomic, and imaging biomarkers can be utilized for disease determination, visualization, and the study of disease transmission.  Associations and distributions differ in their meaning of biomarker. In numerous zones of medication, biomarkers are constrained to proteins identifiable or quantifiable in the blood or pee. Nonetheless, the term is regularly used to cover any atomic, biochemical, physiological, or anatomical property that can be evaluated or estimated.

The National Cancer Institute, specifically, characterizes biomarker as an: "A natural particle found in blood, other body liquids, or tissues that is an indication of an ordinary or irregular process, or of a condition or illness. A biomarker might be utilized to perceive how well the body reacts to a treatment for an ailment or condition.

Hematology Societies in Europe

Association of European Cancer Leagues, Europe; British Society for Haematology, Europe; Egyptian Society of Hematology and Research;  ESMO: European Society for Medical Oncology, Europe; European Academy of Cancer Sciences, Europe; European Association for Cancer Research, Europe; European Cancer Organization: ECCO, Europe; European Organization for Research and Treatment of Cancer, Europe;  European Prostate Cancer Coalition, Europe; European School of Oncology, Europe; European Society for Pediatric Oncology – SIOPE, Europe; European Society of Skin Cancer Prevention, Europe: European Society of Surgical Oncology, Europe;  Federation of European Cancer Societies, Europe; International Society of Pediatric Oncology, Europe;  Organization of European Cancer Institute, Europe

Track-10

Traditional and Alternative Medicine for Blood Cancer

Traditional, complementary and alternative treatment may also be called ‘therapy’ or ‘medicine’.  These treatments are sometimes called ‘holistic’ because they don’t just look at how the disease affects the body, they aim to treat the whole person – emotionally, mentally and spiritually as well as physically. Also the terms "complementary" and "alternative" are here and there used to allude to non-customary strategies for diagnosing, counteracting, or treating cancer or its symptoms overs the same techniques as complementary medicine and the expression is used when these therapies are used instead of conventional treatments.

Some examples of complementary/alternative therapies are given in the box below uses the knowledge and practices developed by the indigenous peoples of North America over thousands of years. It includes using natural plants with healing powers as well as ceremonies such as smudging and sweats. Traditional medicine can be used as either a complementary or alternative treatment for cancer.

Hematology Societies in Asia-Pacific

Asia Pacific Hematology Consortium, Asia-Pacific; Asian and Pacific Federation of Organizations for Cancer Research and Control, Asia-Pacific; Asian Cancer Foundation, Asia-Pacific; Asian Clinical Oncology Society: ACOS, Asia-Pacific; Asian Fund for Cancer Research, Asia-Pacific; Asian Hematology Association, Asia-Pacific; Asian Society of Gynecologic Oncology, Asia-Pacific; Australasian Lung Cancer Trials Group, Asia-Pacific ; Black Sea Countries Coalition on Breast and Cervical Cancer Prevention, Asia-Pacific ; Cancer Therapeutics Research Group, Asia-Pacific; Japanese Society of Hematology, Asia-Pacific ; Pan Arab Hematology Association, Asia-Pacific; The Thai Society of Hematology, Asia-Pacific

Track-11

Anemia and Blood Disorders

A platelet issue is a condition which there's an issue with your red platelets, white platelets, or the more diminutive streaming cells called platelets, which are fundamental for bunch advancement. Every one of the three cells writes frame in the bone marrow, which is the delicate tissue inside your bones

Weakness is a condition that creates when your blood needs enough solid red platelets or hemoglobin. Hemoglobin is a fundamental piece of red platelets and ties oxygen. If you have unnecessarily few or interesting red platelets, or your hemoglobin is irregular or low, the cells in your body won't get enough oxygen.

Mellow iron deficiency regularly causes no side effects. More extreme pallor can cause exhaustion, fair skin, and shortness of breath with effort. Press inadequacy pallor: Iron is vital for the body to make red platelets. Low iron admission and loss of blood because of feminine cycle are the most widely recognized reasons for press insufficiency paleness.

Regular blood issue incorporate pallor, draining disarranges, for example, hemophilia, blood clumps, and blood tumors, for example, leukemia, lymphoma, and myeloma. On the off chance that you are determined to have a blood issue, your specialist may suggest you to a hematologist

Hematology Societies in USA

American Brain Tumor Association, USA; American Cancer Society, USA; American Childhood Cancer Organization, USA; American Head and Neck Society, USA; American Society for Radiation Oncology, USA; American Society of Clinical Oncology, USA; Association of Community Cancer Centers, USA; Canadian Hematology Society, USA; Childhood Brain Tumor Foundation, USA; Children's Tumor Foundation, USA; Colon Cancer Alliance, USA; Foundation for Women's Cancer, USA; International Society for Laboratory Hematology, USA; International Society of Hematology, USA; International Society on Thrombosis and Haemostasis, Inc, USA; Lung Cancer Foundation of America, USA; Lymphoma Research Foundation, USA; Mexican Society of Hematology, USA; Michigan Society of Hematology and Oncology, USA

Track-12

Drugs for Leukemia, Lymphoma and Myeloma

The information  is about a portion of the more current, directed medication medicines for blood tumor that are beginning to be utilized or have been as of late affirmed for use in individuals with Blood Cancer.

The list includes generic and brand names. This page likewise records basic medication mixes utilized as a part of leukemia. The individual medications in the mixes are FDA-endorsed. List of cancer drugs approved by the nourishment and medication Administration for non-Hodgkin lymphoma. Chemotherapy is the utilization of medications to crush or control malignancy cells. These medications can be taken by mouth or given in a vein or a muscle. They enter the circulation system and achieve all regions of the body

Leukemia Drugs:

• Arranon (Nelarabine)
• Asparaginase Erwinia chrysanthemi
• Hyper-CVAD
• Arsenic Trioxide
• Cerubidine (Daunorubicin Hydrochloride)
• Cyclophosphamide
• Alemtuzumab
• Arzerra (Ofatumumab)
• Bendamustine Hydrochloride
• Bendeka (Bendamustine Hydrochloride)

Lymphoma Drugs:

• Doxorubicin
• Bleomycin
• Vinblastine
• Dacarbazine
• Bleomycin
• Etoposide
• Doxorubicin
• Cyclophosphamide
• Vincristine
• Procarbazine

Myeloma Drugs:

• Melphalan
• Vincristine (Oncovin)
• Cyclophosphamide (Cytoxan)
• Etoposide (VP-16)
• Doxorubicin (Adriamycin)
• Liposomal doxorubicin (Doxil)
• Bendamustine (Treanda)   

Hematology Societies in South Africa

Africa Cancer Foundation, Africa; African Cancer Registry Network, Africa; African Journal of Cancer | Mediterranean Oncology Society, Africa; African Organization for Research and Training in Cancer, Africa; African Women’s Cancer Awareness Association, Africa; Afrox - Improving Cancer Care in Africa; CHOC Childhood Cancer Foundation South Africa; Haematology and Oncology Society of Africa; Morocco - World Health Organization Africa; Oncology for Africa ONLUS – Afron, Africa;  South African Clinical Haematology Society, Africa; South African Society of Haematology, Africa; World Health Organisation- Africa Region

Track-13

Organ Specific Cancer

Cancer is one among the leading causes of death all over the world. Organ Specific Cancers are cancers named based on the location of cancer in the body organ. There are different types of cancers which effected different organs of the body ,Some of them are  Head and Neck Cancer, Brain cancer, Lung cancer, Oral cancer, Liver cancer, Breast cancer, Prostate cancer, Gastric cancer, Pancreatic cancer, Kidney cancer, Leukemia and many more. These are different types of cancers that come under category of Organ Specific Cancer. Cancers of the brain are the consequence of abnormal growths of cells in the brain and leads to brain cancer. The most common cancer of the head and neck is Oral squamous cell carcinomas, which accounts for over 300,000 new cancer cases worldwide annually. Hepatocellular carcinoma is the sixth most common cancer and third commonest cause of cancer mortality in the world. Lung, prostate, colon, rectum, stomach and liver are the most common sites affected in men by cancer. The most common sites affected by cancer in women are breast, colon, rectum, lung, cervix and stomach.

Hematology Societies in Europe

Association of European Cancer Leagues, Europe; British Society for Haematology, Europe; Egyptian Society of Hematology and Research;  ESMO: European Society for Medical Oncology, Europe; European Academy of Cancer Sciences, Europe; European Association for Cancer Research, Europe; European Cancer Organization: ECCO, Europe; European Organization for Research and Treatment of Cancer, Europe;  European Prostate Cancer Coalition, Europe; European School of Oncology, Europe; European Society for Pediatric Oncology – SIOPE, Europe; European Society of Skin Cancer Prevention, Europe: European Society of Surgical Oncology, Europe;  Federation of European Cancer Societies, Europe; International Society of Pediatric Oncology, Europe;  Organization of European Cancer Institute, Europe

Track-14

Leukemia Immunology

Cancer immunology is a branch of immunology that studies interactions between the immune system and cancer cells. It is a growing field of research that aims to discover innovative cancer immunotherapies to treat and retard progression of the disease. The immune response, including the recognition of cancer-specific antigens, is of particular interest in the field as knowledge gained drives the development of targeted therapy and tumor marker-based diagnostic tests.

Hematology Societies in Asia-Pacific

Asia Pacific Hematology Consortium, Asia-Pacific; Asian and Pacific Federation of Organizations for Cancer Research and Control, Asia-Pacific; Asian Cancer Foundation, Asia-Pacific; Asian Clinical Oncology Society: ACOS, Asia-Pacific; Asian Fund for Cancer Research, Asia-Pacific; Asian Hematology Association, Asia-Pacific; Asian Society of Gynecologic Oncology, Asia-Pacific; Australasian Lung Cancer Trials Group, Asia-Pacific ; Black Sea Countries Coalition on Breast and Cervical Cancer Prevention, Asia-Pacific ; Cancer Therapeutics Research Group, Asia-Pacific; Japanese Society of Hematology, Asia-Pacific ; Pan Arab Hematology Association, Asia-Pacific; The Thai Society of Hematology, Asia-Pacific

Track-15

Cancer Genomics & Metabolomics

Oncogenomics is a sub-field of genomics that characterizes cancer-associated or cancer related genes. It focuses mainly on genomic, epigenomic and transcript alterations in cancer. The main concept and idea of oncogenomics is to check new group of oncogenes or tumor suppressor genes that may give new areas of research into cancer diagnosis, predicting clinical outcome of cancers and new targets for cancer therapies. The Gleevec, Herceptin and Avastin are the targeted cancer therapies which gave a new way for oncogenomics to elucidate new targets for cancer treatment. Metabolomics is a newly emerging field of 'omics' research and refers to the complete set of small- molecules metabolites, which gives the systematic study of unique chemical fingerprints that leaves cellular processes behind. The metabolome represents the collection of all metabolites in a biological cell, tissue, organ or organism that are the end products of cellular processes. Metabolic profiling gives an instantaneous snapshot of the physiology of the given cell. One of the challenging aspects of systems biology and functional genomics is to integrate proteomic, transcriptomic, and metabolomic information which provide a better understanding of cellular biology.

Hematology Societies in USA

American Brain Tumor Association, USA; American Cancer Society, USA; American Childhood Cancer Organization, USA; American Head and Neck Society, USA; American Society for Radiation Oncology, USA; American Society of Clinical Oncology, USA; Association of Community Cancer Centers, USA; Canadian Hematology Society, USA; Childhood Brain Tumor Foundation, USA; Children's Tumor Foundation, USA; Colon Cancer Alliance, USA; Foundation for Women's Cancer, USA; International Society for Laboratory Hematology, USA; International Society of Hematology, USA; International Society on Thrombosis and Haemostasis, Inc, USA; Lung Cancer Foundation of America, USA; Lymphoma Research Foundation, USA; Mexican Society of Hematology, USA; Michigan Society of Hematology and Oncology, USA

Track-16

Hemato Immunology & Stem Cell Research

Blood groups are of ABO type and but at present the Rh blood grouping of 50 well defined antigens in which 5 are more important they are D,C,c,E and e and Rh factors are of Rh positive and Rh negative which refers to the D-antigen. These D-antigen helps in prevention of erythroblast fetalis lacking of Rh antigen it defined as negative and presences of Rh antigen in blood leads to positive these leads to rh incompatibility. The prevention treatment of diseases related to the blood is called as the Hematology. The hematologists conduct works on cancer to the disorder of immune system leading to hypersensitivity is called as Clinical Immunology and the abnormal growth of an infection are known as Inflammation and the arise of an abnormal immune response to the body or an immune suppression are known as Auto immune disorder. The stem cell therapy is used to treat or prevent a disease or a condition mostly Bone marrow stem cell therapy is seen and recently umbilical cord therapy Stem cell transplantation strategies remains a dangerous procedure with many possible complications; it is reserved for patients with life-threatening diseases.

Track-17

Bone Marrow Transplantation and Surgery

Bone Marrow Transplantation: A bone marrow transplant, also known as a haemopoietic stem cell transplant, replaces damaged bone marrow with healthy bone marrow stem cells. Bone marrow is a spongy tissue found in the hollow centers of some bones. It contains specialist stem cells, which produce the body's blood cells.

A biopsy is a sample of tissue taken from the body in order to examine it more closely. A doctor should recommend a biopsy when an initial test suggests that an area of tissue in the body isn't normal. Doctors may call that area of abnormal tissue a lesion, a tumour, or a mass. Topics of discussion in the scientific sessions are Bone Marrow Surgery, Stem Cell Surgery, Hematopoietic Cell Transplantations.

Hematology Societies in Asia-Pacific

Asia Pacific Hematology Consortium, Asia-Pacific; Asian and Pacific Federation of Organizations for Cancer Research and Control, Asia-Pacific; Asian Cancer Foundation, Asia-Pacific; Asian Clinical Oncology Society: ACOS, Asia-Pacific; Asian Fund for Cancer Research, Asia-Pacific; Asian Hematology Association, Asia-Pacific; Asian Society of Gynecologic Oncology, Asia-Pacific; Australasian Lung Cancer Trials Group, Asia-Pacific ; Black Sea Countries Coalition on Breast and Cervical Cancer Prevention, Asia-Pacific ; Cancer Therapeutics Research Group, Asia-Pacific; Japanese Society of Hematology, Asia-Pacific ; Pan Arab Hematology Association, Asia-Pacific; The Thai Society of Hematology, Asia-Pacific

Track-18

Oncology

Oncology is a branch of medicine that involves the prevention, diagnosis and treatment of cancer. Cancer is a class of diseases characterized by uncontrolled cell growth with the potential to spread to all other parts of the body, which leads to formation of lumps or masses of tissue called tumours. Tumours grow very rapidly and interfere with the digestive, nervous, and circulatory systems and release hormones that fluctuate function of body. Cancer is the major causes of morbidity and mortality worldwide and accounts for nearly 1 of every 4 deaths in US.  Some of the tumour cell does not spread all over the body but they grow uncontrollably like benign tumour. Normal or healthy cell controls their growth and when they become unhealthy they destroys by themselves. A medical professional who practices oncology is known as oncologist.

Hematology Societies in Europe

Association of European Cancer Leagues, Europe; British Society for Haematology, Europe; Egyptian Society of Hematology and Research;  ESMO: European Society for Medical Oncology, Europe; European Academy of Cancer Sciences, Europe; European Association for Cancer Research, Europe; European Cancer Organization: ECCO, Europe; European Organization for Research and Treatment of Cancer, Europe;  European Prostate Cancer Coalition, Europe; European School of Oncology, Europe; European Society for Pediatric Oncology – SIOPE, Europe; European Society of Skin Cancer Prevention, Europe: European Society of Surgical Oncology, Europe;  Federation of European Cancer Societies, Europe; International Society of Pediatric Oncology, Europe;  Organization of European Cancer Institute, Europe

Blood Cancer is a mild term utilized broad for a huge gathering of illnesses that can influence any piece of the body. Metastasis is the huge explanation behind death from threat. The worldwide market for Hematological disease drugs was evaluated to be $18.7 billion of every 2012. By 2017, the market is relied upon to reach $28.8 billion, developing at a CAGR of 9% in the vicinity of 2012 and 2017.The aggregate worldwide market for hematological confusion medications and diagnostics in 2012 was evaluated at about $72.9 billion. By 2018, the market is relied upon to reach $99.1 billion, developing at a compound yearly development rate (CAGR) of 6.4% in the vicinity of 2012 and 2018. The worldwide blood issue advertises fragment is evaluated at $49.3 billion of every 2019 and is required to reach almost $64.7 billion by 2018. The significant purpose behind the low development rate is the normal decrease in the yearly cost of treating blood issue and the patent lapses of Lovenox, Plavix, Procrit/Epogen, Aranesp, and Neulasta. In 2010, every one of these medications together achieved income of $32 billion into the worldwide blood issue advertise.

Scope and Significance

Blood cancer will be the greatest platform for all the Blood cancer researchers, Hematologists, Cancer Specialists, Oncologists, Medical Oncologists, Immunologists, Pathologists, Research Scholars who are into this research field to exchange knowledge and understanding their research works related to Blood cancer. The total concept of this conference is to investigate past the wildernesses in observe in threat like Blood cancer, Leukemia, hematological malignancy, Lung Cancer, Liver Cancer, Breast Cancer, Kidney Cancer, Cancer in adults and sickness in youths.

North America is the main and common business place for growth treats with a bit of about approximate 50% of the general infection treatments promote the extent that wage in 2013, shadowed by Europe which spoke to around approximate 30% offer in the market.

Why Prague